{"id":121681,"date":"2017-06-13T10:01:37","date_gmt":"2017-06-13T10:01:37","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=121681"},"modified":"2017-06-13T10:01:37","modified_gmt":"2017-06-13T10:01:37","slug":"recognized-internationally-for-excellence-in-information-technology-clinical-requirements","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/recognized-internationally-for-excellence-in-information-technology-clinical-requirements_121681.html","title":{"rendered":"Recognized Internationally for Excellence in Information Technology Clinical Requirements"},"content":{"rendered":"<p style=\"text-align: justify;\">Loblaws Pharmaceutical Product Development, North America Division, today announced that Sophia Segal has been Recognized for Excellence in Information Technology Clinical Requirements by Pharmaceutical and Biotechnology executives committee.<\/p>\n<p style=\"text-align: justify;\">Sophia earned top honors in all of the five distinct categories: <strong>contribution, knowledge, critical expertise, quality <\/strong>and <strong>leadership.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/www.abnewswire.com\/uploads\/c55f2b471d1ef07ed3ba5942ed06b398.jpg\" alt=\"\" width=\"170\" height=\"183\" \/><\/strong><br \/><em>Sophia Segal at the Awards Ceremony.<\/em><\/p>\n<p style=\"text-align: justify;\">The results are based on voting responses from both Canada and U.S. from biopharmaceutical industry leader committee responsible for making or influencing decisions to collaborate with contract research organizations (CROs) on clinical development programs.<\/p>\n<p style=\"text-align: justify;\">Leading this committee was Kina Rzayeva, IT Quality Director who &nbsp;has over 20 years international experience in multi-national IT companies in Europe and North America and has held positions of Vice President and Sr. Director.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Loblaws Corporation<br \/><strong>Contact Person:<\/strong> Kina Rzayeva<br \/><strong>Email:<\/strong> customerservice@loblaws.com<br \/><strong>Phone:<\/strong> 9054592500 <br \/><strong>Address:<\/strong>1 President\\&#8217;s Choice Circle  <br \/><strong>City:<\/strong> Toronto<br \/><strong>State:<\/strong> ON, L6Y 5S5<br \/><strong>Country:<\/strong> Canada<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.loblaws.com\/\" target=\"_blank\" rel=\"nofollow\">http:\/\/www.loblaws.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.loblaws.com\/\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=recognized-internationally-for-excellence-in-information-technology-clinical-requirements\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Loblaws Pharmaceutical Product Development, North America Division, today announced that Sophia Segal has been Recognized for Excellence in Information Technology Clinical Requirements by Pharmaceutical and Biotechnology executives committee. Sophia earned top honors in all of the five distinct categories: contribution, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/recognized-internationally-for-excellence-in-information-technology-clinical-requirements_121681.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-121681","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/121681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=121681"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/121681\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=121681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=121681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=121681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}